2nd Oligonucleotide-based Therapeutics Summit

The 2nd Oligonucleotide-Based Therapeutics Summit, taking place from December 8–10, 2026, in Boston, Massachusetts, will bring together leading scientists, researchers, biotech companies and pharmaceutical industry professionals to explore the latest developments in oligonucleotide-based drug development. As RNA-based medicines continue to expand beyond rare genetic diseases into areas such as oncology, neurology and cardiometabolic disorders, the summit will provide an important platform to discuss the scientific advances shaping the next generation of therapeutics.

The three-day event will focus on key challenges and opportunities in oligonucleotide drug discovery and development, including extrahepatic delivery, blood-brain barrier engineering, advanced oligonucleotide chemistry, novel conjugates, circular antisense oligonucleotides (ASOs) and emerging RNA technologies. Attendees will gain insights into new research, development strategies and innovative approaches to improving drug delivery, therapeutic effectiveness and pipeline success.

Featuring more than 22 expert speakers, the summit will include technical presentations, interactive discussions, dedicated workshops and networking opportunities. Participants will have the opportunity to hear directly from industry experts, exchange scientific knowledge, discuss real-world development challenges and learn from the experiences of organisations working across the oligonucleotide therapeutics landscape.

With more than 70 industry leaders expected to participate, the event will provide valuable opportunities for professionals from pharmaceutical and biotechnology companies, academic institutions and technology providers to build connections and explore potential collaborations.

Whether working in RNA therapeutics, antisense oligonucleotides, drug delivery, medicinal chemistry, research and development or preclinical development, attendees can gain practical insights to help advance their programmes and address key challenges in bringing innovative oligonucleotide medicines closer to patients.

The 2nd Oligonucleotide-Based Therapeutics Summit is an important meeting point for professionals looking to understand emerging technologies, share scientific progress and contribute to the future of oligonucleotide-based medicines.

To know more visit: https://ter.li/oi5h1r92